KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Current Taxes: 2022-2024

  • Acadia Pharmaceuticals' Current Taxes was N/A to $8.5 million in Q2 2024 from the same period last year, while for Jun 2024 it was $8.5 million, marking a year-over-year change of. This contributed to the annual value of $8.7 million for FY2023, which is 2210.34% up from last year.
  • According to the latest figures from Q2 2024, Acadia Pharmaceuticals' Current Taxes is $8.5 million, which was up 11.40% from $7.6 million recorded in Q1 2024.
  • In the past 5 years, Acadia Pharmaceuticals' Current Taxes ranged from a high of $8.7 million in Q4 2023 and a low of $377,000 during Q4 2022.
  • In the last 3 years, Acadia Pharmaceuticals' Current Taxes had a median value of $8.5 million in 2023 and averaged $6.7 million.
  • Data for Acadia Pharmaceuticals' Current Taxes shows a peak YoY skyrocketed of 2,210.34% (in 2023) over the last 5 years.
  • Quarterly analysis of 3 years shows Acadia Pharmaceuticals' Current Taxes stood at $377,000 in 2022, then spiked by 2,210.34% to $8.7 million in 2023, then reached $8.5 million in 2024.
  • Its last three reported values are $8.5 million in Q2 2024, $7.6 million for Q1 2024, and $8.7 million during Q4 2023.